Exelixis Inc (EXEL) President and CEO Michael Morrissey Sold $704,654 of Shares
President and CEO of Exelixis Inc (30-Year Financial, Insider Trades) Michael Morrissey (insider trades) sold 35,040 shares of EXEL on 08/14/2019 at an average price of $20.11 a share. The total sale was $704,654.
Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company. Exelixis Inc has a market cap of $6.58 billion; its shares were traded at around $21.72 with a P/E ratio of 10.59 and P/S ratio of 7.47. GuruFocus has detected 1 severe warning sign with Exelixis Inc. .
CEO Recent Trades:
President and CEO Michael Morrissey sold 35,040 shares of EXEL stock on 08/14/2019 at the average price of $20.11. The price of the stock has increased by 8.01% since.
President and CEO Michael Morrissey sold 35,040 shares of EXEL stock on 08/02/2019 at the average price of $20.25. The price of the stock has increased by 7.26% since.
Directors and Officers Recent Trades:
Sr. Vice President, Commercial Patrick J. Haley sold 1,000 shares of EXEL stock on 08/12/2019 at the average price of $20.39. The price of the stock has increased by 6.52% since.
Director George Poste sold 20,000 shares of EXEL stock on 08/09/2019 at the average price of $20.6. The price of the stock has increased by 5.44% since.
Sr. Vice President, Commercial Patrick J. Haley sold 25,000 shares of EXEL stock on 08/06/2019 at the average price of $20.02. The price of the stock has increased by 8.49% since.
Director George A Scangos sold 40,000 shares of EXEL stock on 08/01/2019 at the average price of $20.59. The price of the stock has increased by 5.49% since.
For the complete insider trading history of EXEL, click here
.This article first appeared on GuruFocus.
